Riskpilot← Back to searchSign inGet full accessCapvasc Oy
OYActiveY-tunnus 2080434-8Hirdalvägen 129Medical specialists activities · NACE 8622Est. 2006— employees
Revenue 2025
—
EBITDA margin
—
-179% vs 2024
Equity ratio
97.7%
Financial strength
Net profit 2025
EUR 293K
+15% vs 2024
| Revenue | — | — |
| EBITDA | EUR -79K | -179% |
| Net profit | EUR 293K | +15% |
| Total assets | EUR 1,2M | +20% |
| Equity | EUR 1,2M | +21% |
| Employees | — | — |
Legal name
Capvasc Oy
Y-tunnus number
2080434-8
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
11. joulukuuta 2006
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on lääkäri- ja terveydenhuollon palvelut. Arvopaperikauppa, osakkeiden ja kiinteistöjen omistaminen, hallinta, vuokraus ja kauppa. Yhtiö voi harjoittaa toimintaansa Suomessa ja ulkomailla.
Address
Hirdalvägen 129
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 353 | 418 | 435 | — | — |
| Staff expenses | −22 | −56 | −91 | 62 | −40 |
| EBITDA | 230 | 316 | 293 | 99 | −79 |
| Depreciation & amort. | −4 | −3 | −9 | 23 | −20 |
| EBIT | 226 | 313 | 285 | 322 | 350 |
| Net financials | −0 | −8 | 4 | 12 | 6 |
| Profit before tax | 226 | 305 | 289 | 321 | 366 |
| Tax | 45 | 63 | 58 | 67 | −73 |
| Net profit | 181 | 242 | 231 | 254 | 293 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 457 | 653 | 832 | 1 036 | 1 241 |
| Equity | 433 | 640 | 818 | 1 004 | 1 212 |
| Long-term debt | — | — | 0 | 13 | 0 |
| Short-term debt | 24 | 13 | 14 | 19 | 29 |
| Total debt | 24 | 13 | 14 | 32 | 29 |
EBITDA margin
-7862200.0%
This company
15.8%
Market median
-49760859% vs market
20212025
Equity ratio
97.7%
This company
38.2%
Market median
+156% vs market
20212025
Return on equity
24.2%
This company
18.4%
Market median
+32% vs market
20212025
Net profit margin
29281300.0%
This company
8.1%
Market median
+361497431% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
SA Deputy Member | Deputy Member | 2006 |
JA | Audit | 2023 |
PR Deputy auditor | Deputy auditor | 2023 |
| Former (1) | ||
JT Audit | Audit | 2010 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2006 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Capvasc Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jani Tapani Käsnänen | Audit | 0 companies |
| Sari Anneli Albäck | Deputy Member | 0 companies |
| Jose Adam Juhani Kautonen | Audit | 0 companies |
| Petteri Raine Lagus | Deputy auditor | 0 companies |
| Nils Anders Albäck | Board of Directors | 0 companies |